Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-048346
Filing Date
2020-10-28
Accepted
2020-10-28 16:15:30
Documents
6
Period of Report
2020-12-10
Effectiveness Date
2020-10-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A abio-def14a_20201210.htm DEF 14A 920856
2 GRAPHIC gjttarnektmr000004.jpg GRAPHIC 70615
3 GRAPHIC gjttarnektmr000003.jpg GRAPHIC 2919
4 GRAPHIC gjttarnektmr000005.jpg GRAPHIC 45403
5 GRAPHIC gjttarnektmr000001.jpg GRAPHIC 2919
6 GRAPHIC gjttarnektmr000002.jpg GRAPHIC 2919
  Complete submission text file 0001564590-20-048346.txt   1094712
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 201268823
SIC: 2835 In Vitro & In Vivo Diagnostic Substances